Completed OBSERVATIONAL NCT04460625

Effect of Blood Group on the Survival Status of Intensive Care Patients

Investigation of the Effect of Different Blood Groups on the Survival of Intensive Care Patients

Sponsor: Zonguldak Bulent Ecevit University

Conditions Critical Illness Nurse's Role Prognosis Risk Factor

Updated 6 times since 2020 Last updated: Feb 7, 2022 Started: May 1, 2020 Primary completion: Feb 5, 2022 Completion: Feb 7, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Critical Illness and Nurse's Role and is currently completed. Zonguldak Bulent Ecevit University leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Mar 2022 [monthly]

Recruiting

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Recruiting

First recorded

May 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zonguldak Bulent Ecevit University

Data source: Zonguldak Bulent Ecevit University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zonguldak, Turkey (Türkiye)